Sign in
4

Changes in Ownership

Pasithea Therapeutics Corp. Filed Acc 0001213900-22-034643

Chief Executive Officer acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Marques Tiago Chief Executive Officer 2022-06-23 Grant or award +2,900 $0.99 $2,880 802,900 D
Marques Tiago Chief Executive Officer 2022-06-23 Grant or award +200 $0.98 $196 803,100 D
Marques Tiago Chief Executive Officer 2022-06-23 Grant or award +100 $0.99 $99 803,200 D
Marques Tiago Chief Executive Officer 2022-06-23 Grant or award +1,800 $0.99 $1,789 805,000 D
Loading xslF345X03/ownership.xml…